Replies to post #1813 on Vascular Biogenics Ltd (VBLT)

[sys483]

My understanding is that technically Avastin failed, but still got approved by FDA for rGBM because there are so few treatment options. I guess with so many other drugs failing, it’s not that surprising there is such a low expectation for VB-111.